MLYS
#1910
Mineralys Therapeutics, Inc. - Common Stock
27.6 0 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.04%
Monthly Change
+15.10%
6 month change
-16.36%
Year Change
-31.63%
Previous Close
27.5 9
Open
27.5 5
Low
27.4 8
High
27.6 0
Volume
126
Financials
- Market Capitalization 2.28 B
- Employee 76
- Founded 2019
- CEO N/A
- Website mineralystx.com
- Headquarter Delaware, United States
- FIGI BBG00ZXN1GN3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1896 |  NKTR Nektar Therapeutics - Common Stock | 68.32 USD | 0.00% | -11.04% | +13.36% | -6.76% | 2.31 B USD | ||
| 1909 |  PHVS Pharvaris N.V. - Ordinary Shares | 34.53 USD | -1.54% | +0.70% | +10.35% | +45.21% | 2.25 B USD | ||
| 1911 |  BHVN Biohaven Ltd. Common Shares | 15.01 USD | -1.12% | -3.04% | +30.52% | -11.40% | 2.26 B USD | ||
| 1927 |  ZLAB Zai Lab Limited - American Depositary Shares | 19.43 USD | -0.97% | +0.47% | +10.59% | -27.20% | 2.18 B USD |
Frequently asked questions about Mineralys Therapeutics, Inc. - Common Stock
What is the Mineralys Therapeutics, Inc. - Common Stock stock price today?
The current price of Mineralys Therapeutics, Inc. - Common Stock (MLYS) is 27.6. Over the past 24 hours, the stock has changed by +0.04%. Follow the MLYS chart for real-time price dynamics.
What is the stock ticker of Mineralys Therapeutics, Inc. - Common Stock?
Mineralys Therapeutics, Inc. - Common Stock trades under the ticker MLYS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Mineralys Therapeutics, Inc. - Common Stock stock going up?
MLYS has changed by -10.30% over the last week, +15.10% over the last month, and -31.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Mineralys Therapeutics, Inc. - Common Stock net income for the last quarter?
Mineralys Therapeutics, Inc. - Common Stock reported net income of -39.34 M for the last quarter. The previous quarter showed -32.23 M, which means net income changed by -22.04%.
How many employees does Mineralys Therapeutics, Inc. - Common Stock have?
As of the latest available data, Mineralys Therapeutics, Inc. - Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Mineralys Therapeutics, Inc. - Common Stock stock?
You can buy Mineralys Therapeutics, Inc. - Common Stock (MLYS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Mineralys Therapeutics, Inc. - Common Stock stock?
Investing in Mineralys Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MLYS chart and related analysis on metatrader.com as part of your research.